Schwab Andrew J. - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 14, 2024, Schwab Andrew J.'s relationship to Enliven Therapeutics, Inc. (ELVN) is TenPercentOwner, and currently has 3,200,634 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELVN insiders.
Data Source: SEC.
Schwab Andrew J. - Insider Non-Derivative Transactions of ELVN Common Stock
Schwab Andrew J. - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 15, 2024 | Sell -- (Common Stock) | 136642 | 14.9 | 635341 |
| Feb 15, 2024 | Sell -- (Common Stock) | 688358 | 14.9 | 3200634 |
| Aug 25, 2023 | Sell -- (Common Stock) | 72876 | 16 | 887507 |
| Aug 25, 2023 | Sell -- (Common Stock) | 367124 | 16 | 4470968 |
| Feb 24, 2023 | Acquisition -- (Common Stock) | 960383 | 0 | 960383 |
| Feb 24, 2023 | Acquisition -- (Common Stock) | 4838092 | 0 | 4838092 |